New study determines a neutralizing antibody which binds to the most pandemic strain of norovirus in humans that could be utilized for an effective vaccine.
Browsing: Clinical > Vaccines
A study has revealed genetic variants associated with differing levels of protective antibodies produced after routine immunizations.
A global genomic survey of Streptococcus pneumoniae has identified 621 strains across 50 countries and has highlighted how the bacteria can evolve in response to vaccination.
Take a look at this month’s industry headlines including US FDA approvals for Mavyret (hepatitis C) and Dengvaxia, a rejection for Contepo and profits for Gilead Sciences.
Over 800,000 individuals will be vaccinated against cholera in North Kivu, Democratic Republic of Congo, as the area suffers an unprecedented combination of epidemics.
A cohort of scientists from the Wellcome Sanger Institute, the University of Cambridge, the Peter Doherty Institute for Infection and Immunity and the University of Queensland have identified novel targets using DNA sequencing, bringing research one step closer to developing a universal vaccine against Group A Streptococcus.
Delivering HIV vaccines via slow-release methods has enhanced the protective immune response in preclinical models, according to new research.
Take a look at this month’s industry headlines including news from ViiV Healthcare on long-acting and single dose formulations, sales for Eli Lilly and the possible development of a plague vaccine.
In line with World Immunization Week, we’ve brought together a panel of experts to discuss the issues surrounding vaccine confidence in a ‘post-truth’ world.
A large-scale trial of RTS,S – the world’s first malaria vaccine to provide partial protection – is due to commence in Malawi, Kenya and Ghana.